Tabula Rasa HealthCare Inc (TRHC) Expected to Post Earnings of $0.26 Per Share

Share on StockTwits

Brokerages expect that Tabula Rasa HealthCare Inc (NASDAQ:TRHC) will post earnings per share (EPS) of $0.26 for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Tabula Rasa HealthCare’s earnings. The lowest EPS estimate is $0.20 and the highest is $0.32. Tabula Rasa HealthCare reported earnings per share of $0.09 in the same quarter last year, which indicates a positive year-over-year growth rate of 188.9%. The company is expected to issue its next earnings report on Monday, March 11th.

On average, analysts expect that Tabula Rasa HealthCare will report full-year earnings of $0.82 per share for the current fiscal year, with EPS estimates ranging from $0.68 to $0.96. For the next fiscal year, analysts forecast that the firm will report earnings of $1.13 per share, with EPS estimates ranging from $0.90 to $1.50. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover Tabula Rasa HealthCare.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. The company had revenue of $54.42 million during the quarter, compared to analysts’ expectations of $52.87 million. During the same quarter in the prior year, the company earned $0.08 EPS. The firm’s revenue was up 66.3% on a year-over-year basis.

A number of equities research analysts have recently issued reports on the stock. Stifel Nicolaus assumed coverage on shares of Tabula Rasa HealthCare in a research note on Tuesday, September 11th. They issued a “hold” rating and a $95.00 price objective for the company. Cantor Fitzgerald assumed coverage on shares of Tabula Rasa HealthCare in a research note on Thursday, September 6th. They issued an “overweight” rating and a $99.00 price objective for the company. BidaskClub cut shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 15th. Oppenheimer upped their price objective on shares of Tabula Rasa HealthCare from $65.00 to $86.00 and gave the company an “outperform” rating in a research note on Thursday, August 23rd. Finally, Robert W. Baird upped their price objective on shares of Tabula Rasa HealthCare from $70.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, September 19th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $81.60.

In other Tabula Rasa HealthCare news, CEO Calvin H. Knowlton sold 8,000 shares of the stock in a transaction on Friday, September 7th. The shares were sold at an average price of $85.98, for a total transaction of $687,840.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold a total of 40,000 shares of company stock valued at $3,145,920 in the last three months. 14.00% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Rhumbline Advisers boosted its position in Tabula Rasa HealthCare by 9.4% during the 3rd quarter. Rhumbline Advisers now owns 39,505 shares of the company’s stock valued at $3,207,000 after buying an additional 3,386 shares during the period. Prudential Financial Inc. boosted its position in Tabula Rasa HealthCare by 21.8% during the 3rd quarter. Prudential Financial Inc. now owns 28,500 shares of the company’s stock valued at $2,314,000 after buying an additional 5,100 shares during the period. Dimension Capital Management LLC purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter valued at $461,000. IFG Advisory LLC purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter valued at $378,000. Finally, Virginia Retirement Systems ET AL purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter valued at $365,000. 75.88% of the stock is owned by institutional investors and hedge funds.

Shares of Tabula Rasa HealthCare stock traded up $7.66 during trading on Wednesday, reaching $74.93. The company’s stock had a trading volume of 590,700 shares, compared to its average volume of 347,851. Tabula Rasa HealthCare has a 52-week low of $27.00 and a 52-week high of $91.16. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -1,873.25, a price-to-earnings-growth ratio of 5.88 and a beta of 2.58. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.33 and a current ratio of 0.36.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

See Also: Fundamental Analysis and Individual Investors

Get a free copy of the Zacks research report on Tabula Rasa HealthCare (TRHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply